Production (Stage)
IGC Pharma, Inc.
IGC
$0.3451
$0.00551.62%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 34.55% | -6.52% | 27.80% | 17.57% | 48.38% |
| Total Depreciation and Amortization | -1.91% | 8.28% | -10.49% | -1.22% | 2.50% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 59.84% | -1.80% | -3.48% | -22.84% | -86.62% |
| Change in Net Operating Assets | -1,038.46% | -113.83% | 203.23% | -96.30% | 3,319.23% |
| Cash from Operations | 44.57% | -32.23% | 43.15% | -233.08% | 66.86% |
| Capital Expenditure | 33.33% | 6.90% | 23.68% | -153.33% | 77.94% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -92.21% | -48.08% | 44.09% | 70.00% | -4,528.57% |
| Cash from Investing | -36.54% | -60.00% | 50.38% | 59.44% | -429.51% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 0.00% | 0.00% | -- | 100.00% |
| Issuance of Common Stock | 132.66% | -56.48% | -68.30% | 276.01% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 133.33% | -56.55% | -68.33% | 275.86% | 66,800.00% |
| Foreign Exchange rate Adjustments | -- | 100.00% | -650.00% | 0.00% | 100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 93.96% | -287.05% | -144.41% | 447.78% | 89.08% |